Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Regencell Bioscience ( (RGC) ) has provided an update.
On June 30, 2025, Regencell Bioscience Holdings Limited announced the appointment of Ms. Margaret Hoor Han Lo as an independent director, following the resignation of Mr. Paul J. Niewiadomski. Ms. Lo brings over 30 years of experience in real estate investments and will serve on several key committees. Mr. Niewiadomski resigned for personal reasons and will continue in an advisory role, with no disagreements cited with the company.
More about Regencell Bioscience
Regencell Bioscience Holdings Limited operates within the bioscience industry, focusing on innovative healthcare solutions. The company is incorporated under the laws of the Cayman Islands and is based in Hong Kong.
Average Trading Volume: 3,304,204
Technical Sentiment Signal: Buy
Current Market Cap: $8.6B
Find detailed analytics on RGC stock on TipRanks’ Stock Analysis page.